导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.58% | 621/1050 |
| 近一周 | 0.50% | 46/1104 |
| 近一月 | 4.90% | 9/1102 |
| 近一季 | 3.11% | 193/1092 |
| 近半年 | 1.72% | 391/1070 |
| 近一年 | 0.20% | 589/1018 |
| 近两年 | 38.14% | 614/926 |
| 近三年 | 21.25% | 486/833 |
| 成立以来 | 22.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.75% 896/1070 |
-4.27% 775/1101 |
- - |
- - |
| 2025 | 12.40% 796/1065 |
-0.45% 824/1014 |
10.02% 103/1038 |
-1.80% 1017/1050 |
4.51% 151/1065 |
| 2024 | 28.31% 31/1011 |
3.76% 141/960 |
3.87% 136/983 |
17.31% 125/991 |
1.48% 259/1011 |
| 2023 | -22.53% 737/952 |
-7.97% 838/880 |
-6.16% 588/895 |
0.17% 80/915 |
-10.45% 873/952 |
| 2022 | -16.91% 219/867 |
-4.36% 27/773 |
3.34% 615/806 |
-20.24% 761/845 |
5.40% 183/867 |
| 2021 | -2.89% 396/740 |
6.59% 38/580 |
-3.52% 573/659 |
-5.43% 370/704 |
-0.15% 446/740 |
| 2020 | 7.72% 402/554 |
-13.39% 399/419 |
3.95% 418/466 |
12.80% 184/517 |
6.06% 418/554 |
| 2019 | 39.02% 227/410 |
24.32% 757/1146 |
0.92% 240/1228 |
0.88% 312/390 |
9.84% 163/410 |
| 2018 | - - |
- - |
-1.62% 108/990 |
6.81% 41/1000 |
-9.61% 264/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 嘉实金融精选股票C VS. 东吴新产业精选股票A(580008) |